Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L Buisseret, S Pommey, B Allard, S Garaud, M Bergeron, I Cousineau, L Ameye, Y Bareche, M Paesmans, JPA Crown, A Di Leo, S Loi, M Piccart-Gebhart, K Willard-Gallo, C Sotiriou, J Stagg
Annals of Oncology | OXFORD UNIV PRESS | Published : 2018
Awarded by Canadian Institutes of Health Research (CIHR)
This work was supported by a Project Grant from the Canadian Institutes of Health Research (CIHR, grant number: 364476). JS is supported by the Famille Jean-Guy Sabourin Research Chair in Pharmacology. LB is a fellow of the Belgian Fund for Scientific Research (FRS-FNRS).